COVID-19 Treatment

Play Video

Meet your experts, Ajit Johal and John Papastergiou!

Check out clinical and operational strategies pertaining to COVID-19 treatment in high-risk populations from pharmacist experts Ajit and John.

Discover the power of Artificial Intelligence: A new learning course for pharmacists on COVID-19 treatment.

Session Description

Discover a new revolutionary AI-powered learning course on COVID-19 treatment featuring pharmacy experts Ajit Johal (BC), John Papastergiou (ON), and Paraag Trivedi (SASK). This interactive learning program is the first of its kind! Featuring generative AI to simulate patient case scenarios and disseminate expert knowledge. Learning is focused on leveraging tools and resources to emphasize implementation and improve patient outcomes.

Session 1: May 24th 2023 7:00pm ET - Ontario

Featuring: Speaker John Papstergiou , Moderators - Ajit Johal, Mark Zhou

  1. Determine patient eligibility for COVID-19 treatment in Ontario based on the provincial eligibility criteria
  2. Evaluate Drug-Drug Interaction (DDI) Management Strategies
  3. Develop operational strategies for COVID-19 treatment assessment at the Community Pharmacy.
  4. Discuss proactive “action-planning” leveraging clinical services such as the Ontario Medscheck program to identify vulnerable patients eligible for COVID-19 treatment

Session 2: May 24th 2023 6:00pm PT - BC

Featuring: Speaker Ajit Johal, Moderator - Mark Zhou

  1. Determine patient eligibility for COVID-19 treatment in British Columbia based on the provincial eligibility criteria
  2. Evaluate Drug-Drug Interaction (DDI) Management Strategies
  3. Develop operational strategies for COVID-19 treatment assessment at the Community Pharmacy.
  4. Discuss proactive “action-planning” leveraging clinical services such as the BC Medication Review Services program to identify vulnerable patients eligible for COVID-19 treatment

Session 3: June 7th 2023 6:00pm CST - Sask

Featuring: Speaker Paraag Trivedi, Moderator - Ajit Johal

  1. Determine patient eligibility for COVID-19 treatment in Saskatchewan based on the provincial eligibility criteria
  2. Evaluate Drug-Drug Interaction (DDI) Management Strategies
  3. Develop operational strategies for COVID-19 treatment assessment at the Community Pharmacy.
  4. Discuss proactive “action-planning” leveraging clinical services such as the Saskatchewan Medication Assessment Program to identify vulnerable patients eligible for COVID-19 treatment

How would YOU handle this patient's concerns in YOUR practice?

Work through AI-powered patient scenarios you could see in your practice. Learn about the latest guidelines on COVID-19 treatment eligibility, and operational strategies to best support your patients.

Check out our learning course